These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 1096989

  • 1. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH.
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [Abstract] [Full Text] [Related]

  • 2. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE.
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [Abstract] [Full Text] [Related]

  • 3. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH, Rich RR, Smith TK.
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [Abstract] [Full Text] [Related]

  • 4. Transfer factor II: results of therapy.
    Spitler LE, Levin AS, Fudenberg HH.
    Birth Defects Orig Artic Ser; 1975 Nov; 11(1):449-56. PubMed ID: 1096990
    [Abstract] [Full Text] [Related]

  • 5. Transfer factor as an approach to the treatment of immune deficiency disease.
    Schulkind ML, Ayoub EM.
    Birth Defects Orig Artic Ser; 1975 Nov; 11(1):436-40. PubMed ID: 1096988
    [Abstract] [Full Text] [Related]

  • 6. Transfer factor therapy in immuno-deficiencies.
    Griscelli C, Revillard JP, Betuel H, Herzog C, Touraine JL.
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract] [Full Text] [Related]

  • 7. Transfer factor therapy in immunodeficiency.
    Griscelli C.
    Birth Defects Orig Artic Ser; 1975 May; 11(1):462-4. PubMed ID: 1148388
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z.
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract] [Full Text] [Related]

  • 9. Transfer factor therapy: evidence for nonspecificity.
    Ballow M, Dupont B, Hansen JA, Good RA.
    Birth Defects Orig Artic Ser; 1975 Nov; 11(1):457-61. PubMed ID: 125119
    [Abstract] [Full Text] [Related]

  • 10. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M, Krohn K, Virolainen M, Blomqvist K.
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [Abstract] [Full Text] [Related]

  • 11. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP.
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [Abstract] [Full Text] [Related]

  • 12. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM, Drexhage HA, Kokjé-Kleingeld M, Leezenberg HA.
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [Abstract] [Full Text] [Related]

  • 13. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP, Lolekha S, Lopata M, Kopp J, Kopp RL, Malecki TJ.
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract] [Full Text] [Related]

  • 14. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE, Levin AS, Stites DP, Fudenberg HH, Pirofsky B, August CS, Stiehm ER, Hitzig WH, Gatti RA.
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [Abstract] [Full Text] [Related]

  • 15. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K, Nomoto K, Matsumoto T, Miyake T, Himeno K.
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [Abstract] [Full Text] [Related]

  • 16. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
    Valdimarsson H, Wood CB, Hobbs JR, Holt PJ.
    Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
    [Abstract] [Full Text] [Related]

  • 17. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H, Hanson LA, Lindholm L, Ljunggren C.
    Acta Derm Venereol; 1980 Jun; 60(1):51-5. PubMed ID: 6153834
    [Abstract] [Full Text] [Related]

  • 18. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C, Jontell M, Bergenholtz G, Dahlgren UI.
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [Abstract] [Full Text] [Related]

  • 19. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
    Elliott ST, Hanifin JM.
    Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.